Published in Antimicrob Agents Chemother on April 01, 1987
Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrob Agents Chemother (1991) 4.36
Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob Agents Chemother (1992) 3.09
Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans. J Clin Microbiol (1992) 2.12
Improved method for azole antifungal susceptibility testing. J Clin Microbiol (1988) 1.86
Carrier effects on biological activity of amphotericin B. Clin Microbiol Rev (1996) 1.85
Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans. Antimicrob Agents Chemother (1988) 1.31
In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method. Antimicrob Agents Chemother (1992) 1.09
Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis. Genitourin Med (1993) 0.83
Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size. Antimicrob Agents Chemother (1976) 8.54
Azole resistance in Candida albicans. Sabouraudia (1984) 6.23
Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods. Antimicrob Agents Chemother (1978) 5.94
Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts. J Clin Microbiol (1986) 3.40
Effects of pH on the activity of ketoconazole against Candida albicans. Antimicrob Agents Chemother (1983) 3.06
Problems in the laboratory assessment of antifungal activity. Postgrad Med J (1979) 2.43
In-vitro resistance to imidazole antifungals in Candida albicans. J Antimicrob Chemother (1984) 2.43
Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans. Antimicrob Agents Chemother (1984) 1.88
Antifungal drug susceptibility testing. A critical review. Mycopathologia (1984) 1.27
Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use. Antimicrob Agents Chemother (1984) 1.21
Ketoconazole and the liver. Lancet (1982) 1.04
Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits. J Antimicrob Chemother (1986) 1.01
Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother (1990) 8.42
Inorganic phosphate transport in Escherichia coli: involvement of two genes which play a role in alkaline phosphatase regulation. J Bacteriol (1973) 4.16
Constitutive expression of the iron-enterochelin and ferrichrome uptake systems in a mutant strain of Salmonella typhimurium. J Bacteriol (1978) 3.21
Momentum versus extinction effects in the treatment of self-injurious escape behavior. J Appl Behav Anal (1993) 2.23
Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and Is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem Biophys Res Commun (1999) 2.18
Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol (2000) 1.99
Arsenate resistant mutants of Escherichia coli and phosphate transport. Biochem Biophys Res Commun (1970) 1.98
Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans. Antimicrob Agents Chemother (1984) 1.88
Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell (1989) 1.85
Immunodetection and partial cDNA sequence of the proteoglycan, superficial zone protein, synthesized by cells lining synovial joints. J Orthop Res (1999) 1.68
Identification of the site of autophosphorylation of the bacterial protein kinase/phosphatase NRII. J Biol Chem (1991) 1.63
Genetic and physiological regulation of intrinsic proteins of the outer membrane of Salmonella typhimurium. J Bacteriol (1976) 1.60
Why do DNA testing? Practical and ethical implications of new neurogenetic tests. Ann Neurol (1995) 1.57
Mechanism for the pyridoxal neutralization of isoniazid action of Mycobacterium tuberculosis. J Bacteriol (1967) 1.49
Nonspecific ionic inhibition of ethambutol binding by Mycobacterium smegmatis. Antimicrob Agents Chemother (1973) 1.43
Patient-controlled analgesia. Ann Intern Med (1983) 1.42
Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species. J Antimicrob Chemother (1983) 1.41
Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans. Antimicrob Agents Chemother (1988) 1.31
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp. Antimicrob Agents Chemother (1984) 1.29
Synergistic action of amphotericin B and rifampin against Candida species. J Infect Dis (1976) 1.28
Aortic root complications in Marfan's syndrome: identification of a lower risk group. Heart (1996) 1.27
Synergistic action of amphotericin B and rifampin on Candida albicans. Am Rev Respir Dis (1974) 1.26
Catabolism of aggrecan, decorin and biglycan in tendon. Biochem J (2000) 1.26
Intramural hematoma of the gastrointestinal tract. Am J Surg (1977) 1.23
Role of ionic strength in salt antagonism of aminoglycoside action on Escherichia coli and Pseudomonas aeruginosa. J Infect Dis (1976) 1.22
Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase. Osteoarthritis Cartilage (1998) 1.21
Expression and activity of articular cartilage hyaluronidases. Biochem Biophys Res Commun (1998) 1.20
Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B. Antimicrob Agents Chemother (1976) 1.20
Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J (1999) 1.18
DNA sequence, structure, and tyrosine kinase activity of the Drosophila melanogaster Abelson proto-oncogene homolog. Mol Cell Biol (1988) 1.18
Role and regulation of metalloproteinases in connective tissue turnover. Biochem Soc Trans (1990) 1.17
Intercontinental dispersal prior to human translocation revealed in a cryptogenic invasive tree. New Phytol (2007) 1.16
Surgical management of ventricular tachycardia in subannular left ventricular aneurysm. Ann Thorac Surg (1995) 1.16
IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage. Matrix Biol (2000) 1.16
Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthritis Cartilage (2009) 1.15
Articular cartilage metabolism in patients with Kashin-Beck Disease: an endemic osteoarthropathy in China. Osteoarthritis Cartilage (2007) 1.15
Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles. J Antimicrob Chemother (1987) 1.15
Distinct roles of the homeotic genes Ubx and abd-A in beetle embryonic abdominal appendage development. Proc Natl Acad Sci U S A (2000) 1.11
The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. J Thromb Haemost (2009) 1.09
Time-resolved rotational dynamics of phosphorescent-labeled myosin heads in contracting muscle fibers. Biochemistry (1990) 1.09
Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem J (1994) 1.09
Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc (1992) 1.09
Liquid chromatographic assay of ketoconazole. Antimicrob Agents Chemother (1981) 1.08
Galactose repression of beta-galactosidase induction in Escherichia coli. J Bacteriol (1966) 1.08
Isoniazid uptake and growth inhibition of Mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposures. Tubercle (1969) 1.07
Racial variation in the use of laparoscopic cholecystectomy in the Department of Veterans Affairs medical system. J Am Coll Surg (1999) 1.05
The REC1 gene of Ustilago maydis, which encodes a 3'-->5' exonuclease, couples DNA repair and completion of DNA synthesis to a mitotic checkpoint. Genetics (1996) 1.04
Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. J Med Genet (1992) 1.03
Airway-obstructing supraglottic edema following anesthesia with the head positioned in forced flexion. Anesthesiology (1981) 1.03
Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet (1994) 1.02
Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections. Obstet Gynecol (1981) 1.02
Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits. J Antimicrob Chemother (1986) 1.01
n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem (2000) 1.01
Isoniazid uptake in relation to growth inhibition of Mycobacterium tuberculosis. J Bacteriol (1968) 1.01
The learning curve for AIDS-related Pneumocystis carinii pneumonia: experience from 3,981 cases in Veterans Affairs Hospitals 1987-1991. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.01
Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs. Antimicrob Agents Chemother (1984) 1.01
Chemical characterization of ethambutol binding to Mycobacterium smegmatis. Antimicrob Agents Chemother (1974) 1.01
Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis. Acta Orthop Scand Suppl (1995) 1.00
Mutation avoidance and DNA repair proficiency in Ustilago maydis are differentially lost with progressive truncation of the REC1 gene product. Mol Cell Biol (1995) 0.98
Influence of antioxidants on the bioactivity of amphotericin B. Antimicrob Agents Chemother (1977) 0.97
Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem J (1993) 0.96
Expression of ADAMTS homologues in articular cartilage. Biochem Biophys Res Commun (1999) 0.94
Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration. Osteoarthritis Cartilage (2005) 0.93
Inhibition of dihydrostreptomycin binding to Mycobacterium smegmatis by monovalent and divalent cation salts. Antimicrob Agents Chemother (1976) 0.92
Action of imidazole-containing antifungal drugs. Life Sci (1981) 0.92
A role for adhesion and degranulation-promoting adapter protein in collagen-induced platelet activation mediated via integrin α(2) β(1). J Thromb Haemost (2012) 0.92
Streptomycin uptake by Mycobacterium tuberculosis. Appl Microbiol (1971) 0.92
Uptake and binding of 14C-ethambutol by tubercle bacilli and the relation of binding to growth inhibition. Antimicrob Agents Chemother (1972) 0.91
Development of the Critical Elements of Genetic Evaluation and Genetic Counseling for Genetic Professionals and Perinatologists in Washington State. J Genet Couns (1998) 0.91
Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences. J Pharmacol Exp Ther (1993) 0.90
A 5-year audit of outcome of apicectomies carried out in a district general hospital. Ann R Coll Surg Engl (1995) 0.90
Diffusion of laparoscopic cholecystectomy in the Veterans Affairs health care system, 1991-1995. Eff Clin Pract (1999) 0.90
Does individual programme size affect screening performance? Results from the United Kingdom NHS breast screening programme. J Med Screen (2002) 0.89
Efficacy of human lymphoblastoid interferon in the therapy of resistant condyloma acuminata. Obstet Gynecol (1986) 0.88
Reduction of lipoplasty risks and mortality: an ASAPS survey. Aesthet Surg J (2001) 0.88
Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors. JAMA (1997) 0.87
Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin. Am Rev Respir Dis (1973) 0.87
Synergistic action of amphotericin B and antioxidants against certain opportunistic yeast pathogens. Antimicrob Agents Chemother (1978) 0.87
Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet (1995) 0.86
Uptake of ethambutol by Mycobacterium smegmatis and its relation to growth inhibition. Am Rev Respir Dis (1973) 0.86
Interferon for the therapy of condyloma acuminatum. Am J Obstet Gynecol (1985) 0.85
Compositions of particles from selected sources in Philadelphia for receptor modeling applications. JAPCA (1988) 0.85
Exploitation of the direct cell damaging action of antifungal azoles. Diagn Microbiol Infect Dis (1987) 0.84
Primary binding of ethambutol by Mycobacterium smegmatis. Am Rev Respir Dis (1973) 0.84
PKR negatively regulates leukemia progression in association with PP2A activation, Bcl-2 inhibition and increased apoptosis. Blood Cancer J (2013) 0.84
Key pecking during extinction after intermittent or continuous reinforcement as a function of the number of reinforcers delivered during training. J Exp Anal Behav (1997) 0.84
Regulatory function of hydrogen ion on the direct lethal action of miconazole. J Antimicrob Chemother (1987) 0.84
Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity. Clin Pharm (1983) 0.83
High-pressure liquid chromatographic assay of Bay n 7133 in human serum. Antimicrob Agents Chemother (1984) 0.83
Nonspecificity in the divalent cation antagonism of dihydrostreptomycin action on Mycobacterium smegmatis. Res Commun Chem Pathol Pharmacol (1975) 0.83
The effect of changing from one to two views at incident (subsequent) screens in the NHS breast screening programme in England: impact on cancer detection and recall rates. Clin Radiol (2005) 0.83
Globular adiponectin induces platelet activation through the collagen receptor GPVI-Fc receptor gamma chain complex. J Thromb Haemost (2008) 0.83
Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans. Res Commun Chem Pathol Pharmacol (1982) 0.83